The ASX slipped at lunch as oil fired up inflation fears and energy stocks hogged the action.
The developer of cannabis-based therapies for childhood disorders, Neurotech has won valuable Investigational New Drug status from the FDA.
The United States CMS proposes to maintain the reimbursement framework for outpatient skin substitute products through CY27.
Morning Feed plates up early sharemarket movers, announcements and company news, serving investors a quick hit of market action and updates from selected ASX-listed companies.
The work is part of the company’s push to validate Shafter’s 17.57Moz foreign mineral resource.
